AOL Money & Finance

Option Update: Teva Pharmaceutical volatility flat; shares sell off

Posted Jul 7th 2008 9:44AM by Paul FosterPaul Foster RSS Feed
Filed under: Options, Teva Pharm Indus ADR (TEVA)

More

Teva Pharmaceutical (NASDAQ: TEVA) is recently down $3.05 to $44.15 in pre-open trading after announcing that late-stage, top-line results showed the 40mg dose of its multiple sclerosis drug Copaxone was not more effective in reducing the relapse rate than the 20mg dose already approved.

TEVA overall option implied volatility of 25 is near its 26-week average according to Track Data, suggesting non-directional movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Tags: copaxone, inthenews, option implied volatility, OptionImpliedVolatility, teva

Symbol Lookup
IndexesChangePrice
DJIA+34.6910,281.66
NASDAQ+12.582,163.66
S&P 500+4.961,097.97

Last updated: November 11, 2009: 03:00 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines